TEL AVIV/NEW YORK (Reuters) - Generic drugmaker Teva Pharmaceutical Industries Ltd. said on Tuesday that it had proposed buying rival Mylan for $82.00 per share in a mix of stock and cash.
Teva said the offer was a 48-percent premium to the stock price of MYLAN (MYL.NQ)(MYL.NQ)on March 10, 2015, which it said was "the last day of trading prior to widespread speculation of a transaction between Teva and Mylan."
(Reporting by Caroline Humer; Editing by Alden Bentley)
Relacionados
- Japanese PM Abe makes ritual offering at Yasukuni shrine, irks neighbours
- Japanese PM Abe makes ritual offering at Yasukuni shrine
- John Travolta makes surprise gift to Florida arts center
- Ivory-smuggling destination Thailand makes 'biggest seizure' of tusks
- Indonesia flight makes emergency landing, no bomb found